The role of host genetics in leishmaniasis

Trends in Parasitology

Volumn 25, Issue 8, 2009, Pages 383-391

  Sakthianandeswaren, Anuratha ^a,b   Foote, Simon J ^c   Handman, Emanuela ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MODIFICATION; GENE IDENTIFICATION; GENE LOCUS; HOST; HUMAN; LEISHMANIASIS; NONHUMAN; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEINS; SPECIES SPECIFICITY;

HEXAPODA;

EID: 67949108153     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2009.05.004     Document Type: Review

References (69)

1. WHO, Leishmaniasis. http://www.who.int/topics/leishmaniasis/en/
2. Alvar J., et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin. Microbiol. Rev. 21 (2008) 334-359
3. Murray H.W., et al. Advances in leishmaniasis. Lancet 366 (2005) 1561-1577
4. Banuls A.L., et al. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv. Parasitol. 64 (2007) 1-109
5. Chappuis F., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 5 (2007) 873-882
6. Amato V.S., et al. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta Trop. 105 (2008) 1-9
7. Cabello P.H., et al. Familial aggregation of Leishmania chagasi infection in northeastern Brazil. Am. J. Trop. Med. Hyg. 52 (1995) 364-365
8. Rogers M.E., et al. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 430 (2004) 463-467
9. Handman E., et al. Genes and susceptibility to leishmaniasis. Adv. Parasitol. 59 (2005) 1-75
10. Carrion J., et al. Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol. 28 (2006) 173-183
11. Vladimirov V., et al. Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice. Infect. Immun. 71 (2003) 2041-2046
12. Mahmoudzadeh-Niknam H., et al. Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. Korean J. Parasitol. 45 (2007) 247-253
13. Foote S.J., and Handman E. Genetics of murine leishmaniasis. Brief. Funct. Genomics Proteomics 4 (2005) 270-276
14. Elso C., et al. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major. Genes Immun. 5 (2004) 188-196
15. Elso C.M., et al. Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun. 5 (2004) 93-100
16. Roberts L.J., et al. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J. Exp. Med. 185 (1997) 1705-1710
17. Roberts L.J., et al. Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection. Eur. J. Immunol. 29 (1999) 3047-3050
18. Sakthianandeswaren A., et al. The wound repair response controls outcome to cutaneous leishmaniasis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15551-15556
19. Beebe A.M., et al. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6 (1997) 551-557
20. Beebe A.M., et al. Genetic control of T helper subset differentiation in Leishmania major infection of mice. Microbes Infect. 1 (1999) 89-94
21. Baguet A., et al. A Leishmania major response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus. J. Exp. Med. 200 (2004) 1605-1612
22. Havelkova H., et al. Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun. 7 (2006) 220-233
23. Lipoldova M., and Demant P. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat. Rev. Genet. 7 (2006) 294-305
24. Howard J.G., et al. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 2 (1980) 303-314
25. Terabe M., et al. Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensis. Parasitol. Int. 53 (2004) 217-221
26. Fortier A., et al. Single gene effects in mouse models of host: pathogen interactions. J. Leukoc. Biol. 77 (2005) 868-877
27. Vidal S.M., et al. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73 (1993) 469-485
28. Blackwell J.M., et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell. Microbiol. 3 (2001) 773-784
29. Kirkpatrick C.E., and Farrell J.P. Leishmaniasis in beige mice. Infect. Immun. 38 (1982) 1208-1216
30. Perou C.M., et al. Identification of the murine beige gene by YAC complementation and positional cloning. Nat. Genet. 13 (1996) 303-308
31. Russell J.H., and Ley T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20 (2002) 323-370
32. Wilson J., et al. Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog. 4 (2008) e1000179
33. Blackwell J., et al. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 283 (1980) 72-74
34. DeTolla L.J., et al. Genetic control of acquired resistance to visceral leishmaniasis in mice. Immunogenetics 10 (1980) 353-361
35. Leclerc C., et al. Systemic infection of Leishmania tropica (major) in various strains of mice. Trans. R. Soc. Trop. Med. Hyg. 75 (1981) 851-854
36. Frazer K.A., et al. Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 10 (2009) 241-251
37. Bucheton B., et al. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am. J. Hum. Genet. 73 (2003) 1052-1060
38. Bucheton B., et al. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun. 8 (2007) 79-83
39. Miller E.N., et al. Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. PLoS Genet. 3 (2007) e71
40. Bucheton B., et al. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun. 4 (2003) 104-109
41. Mohamed H.S., et al. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur. J. Hum. Genet. 12 (2004) 66-74
42. Mohamed H.S., et al. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun. 4 (2003) 351-355
43. Salih M.A., et al. IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun. 8 (2007) 75-78
44. Jamieson S.E., et al. Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun. 8 (2007) 84-90
45. Jeronimo S.M., et al. Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan. J. Infect. Dis. 196 (2007) 1261-1269
46. Jeronimo S.M., et al. Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun. 8 (2007) 539-551
47. Kamali-Sarvestani E., et al. Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 35 (2006) 159-165
48. Salhi A., et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J. Immunol. 180 (2008) 6139-6148
49. Cabrera M., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182 (1995) 1259-1264
50. Castellucci L., et al. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J. Infect. Dis. 194 (2006) 519-527
51. Olivo-Diaz A., et al. Role of HLA class II alleles in susceptibility to and protection from localized cutaneous leishmaniasis. Hum. Immunol. 65 (2004) 255-261
52. Petzl-Erler M.L., et al. Association of mucosal leishmaniasis with HLA. Hum. Immunol. 32 (1991) 254-260
53. Barbier D., et al. Susceptibility to human cutaneous leishmaniasis and HLA, Gm, Km markers. Tissue Antigens 30 (1987) 63-67
54. Lara M.L., et al. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum. Immunol. 30 (1991) 129-135
55. Mansueto P., et al. Immunopathology of leishmaniasis: an update. Int. J. Immunopathol. Pharmacol. 20 (2007) 435-445
56. Couper K.N., et al. IL-10: the master regulator of immunity to infection. J. Immunol. 180 (2008) 5771-5777
57. Blackwell J.M., et al. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 85 (2003) 197-203
58. Infante-Duarte C., and Kamradt T. Th1/Th2 balance in infection. Springer Semin. Immunopathol. 21 (1999) 317-338
59. Elamin E.M., et al. Identification of Leishmania donovani as a cause of cutaneous leishmaniasis in Sudan. Trans. R. Soc. Trop. Med. Hyg. 102 (2008) 54-57
60. Svobodova M., et al. Cutaneous leishmaniasis caused by Leishmania infantum transmitted by Phlebotomus tobbi. Int. J. Parasitol. 39 (2009) 251-256
61. Alborzi A., et al. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Am. J. Trop. Med. Hyg. 79 (2008) 435-437
62. Barral A., et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg. 44 (1991) 536-546
63. Badalova J., et al. Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice. Genes Immun. 3 (2002) 187-195
64. Lipoldova M., et al. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun. 1 (2000) 200-206
65. Karplus T.M., et al. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect. Immun. 70 (2002) 6919-6925
66. Sharma U., and Singh S. Insect vectors of Leishmania: distribution, physiology and their control. J. Vector Borne Dis. 45 (2008) 255-272
67. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35 (2005) 1169-1180
68. Volf P., et al. Molecular crosstalks in Leishmania-sandfly-host relationships. Parasite 15 (2008) 237-243
69. Bates P.A., and Rogers M.E. New insights into the developmental biology and transmission mechanisms of Leishmania. Curr. Mol. Med. 4 (2004) 601-609